Pixie Dust Technologies Inc Quick Ratio (PXDT) starting from the fourth quarter 2024 to fourth quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Pixie Dust Technologies Inc   (NASDAQ: PXDT)

Pixie Dust Technologies Inc 's Quick Ratio

PXDT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2024, Quick Ratio fell to 3.22 above Pixie Dust Technologies Inc average.

Within Medical Equipment & Supplies industry 52 other companies have achieved higher Quick Ratio than Pixie Dust Technologies Inc in fourth quarter 2024. While Quick Ratio total ranking in the fourth quarter 2024 has deteriorated compared to the prior quarter from 776 to 881.

Explain Quick Ratio?
How much Cash & cash equivalents PXDT´s has?
What are PXDT´s Current Liabilities?




PXDT Quick Ratio (Apr 30 2024)
Q4
0
Q3
0
Q2
0
Q1
(Apr 30 2023)
Q4
Y / Y Current Liabilities Change -67.5 % -77.61 % -25.52 % -77.61 % 341.77 %
Y / Y Cash & cash equivalent Change -31.07 % -35.01 % 7.56 % -35.01 % 13.04 %
Quick Ratio MRQ 3.22 3.51 1.75 3.51 1.52
PXDT's Total Ranking # 881 # 776 # 838 # 838 # 1731
Seq. Current Liabilities Change 18.25 % -69.94 % 232.62 % -72.52 % -18.52 %
Seq. Cash & cash equivalent Change 8.55 % -39.58 % 65.51 % -36.5 % 2.34 %



Quick Ratio fourth quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 53
Healthcare Sector # 437
Overall Market # 881


Quick Ratio Statistics
High Average Low
3.51 2.36 1.21
(Apr 30 2024)   (Apr 30 2023)




Financial Statements
Pixie Dust Technologies Inc 's Current Liabilities $ 3 Millions Visit PXDT's Balance sheet
Pixie Dust Technologies Inc 's Cash & cash equivalent $ 11 Millions Visit PXDT's Balance sheet
Source of PXDT's Sales Visit PXDT's Sales by Geography


Cumulative Pixie Dust Technologies Inc 's Quick Ratio

PXDT's Quick Ratio for the trailling 12 Months

PXDT Quick Ratio

(Apr 30 2024)
12 Months
0
12 Months
0
12 Months
0
12 Months
(Apr 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth -61.79 % -36.96 % 27.43 % 156.55 % 1968.31 %
Y / Y Cash & cash equivalent TTM Growth -23.43 % -12.97 % 29.03 % 92.79 % 344.39 %
Quick Ratio TTM 2.56 2.05 1.63 1.46 1.27
Total Ranking TTM # 3421 # 3533 # 3630 # 0 # 4398
Seq. Current Liabilities TTM Growth -27.4 % -27.88 % -8.4 % -20.34 % 19.79 %
Seq. Cash & cash equivalent TTM Growth -9.36 % -9.34 % 2.06 % -8.7 % 3.02 %


On the trailing twelve months basis Current Liabilities decreased faster than Pixie Dust Technologies Inc 's average Cash & cash equivalent, this led to increase in in Pixie Dust Technologies Inc 's Quick Ratio to 2.56, above PXDT average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 212 other companies have achieved higher Quick Ratio than Pixie Dust Technologies Inc . While Quick Ratio overall ranking has improved so far to 3421, from total ranking during the twelve months ending third quarter 2024 at 3533.

Explain Quick Ratio?
How much Cash & cash equivalents PXDT´s has?
What are PXDT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 213
Healthcare Sector # 963
Within the Market # 3421


trailing twelve months Quick Ratio Statistics
High Average Low
3.51 2.28 1.21
(Apr 30 2024)   (Apr 30 2023)




Companies with similar Quick Ratio in the quarter ending Apr 30 2024, within Medical Equipment & Supplies Industry Quick RatioApr 30 2024 MRQ Cash & cash equivalentApr 30 2024 MRQ Current Liabilities
Modular Medical Inc  8.53 $ 9.232  Millions$ 1.082  Millions
Silk Road Medical Inc   8.18 $ 174.462  Millions$ 21.337  Millions
Orchestra Biomed Holdings Inc   7.54 $ 75.038  Millions$ 9.951  Millions
Irhythm Holdings Inc   7.25 $ 569.092  Millions$ 78.484  Millions
Hyperfine Inc   7.21 $ 63.204  Millions$ 8.767  Millions
Transmedics Group Inc   6.97 $ 350.217  Millions$ 50.223  Millions
Inspiremd Inc   6.96 $ 33.950  Millions$ 4.877  Millions
Axonics Inc   6.88 $ 332.806  Millions$ 48.387  Millions
Rxsight Inc   6.84 $ 125.354  Millions$ 18.328  Millions
Microbot Medical Inc   6.45 $ 6.397  Millions$ 0.992  Millions
U S Physical Therapy Inc  6.39 $ 132.290  Millions$ 20.718  Millions
Avita Medical Inc   6.09 $ 72.283  Millions$ 11.862  Millions
Akili Inc   6.05 $ 63.161  Millions$ 10.433  Millions
Nutriband Inc   6.00 $ 8.348  Millions$ 1.391  Millions
Iradimed Corporation  5.92 $ 45.127  Millions$ 7.617  Millions
Procept Biorobotics Corporation  5.84 $ 225.576  Millions$ 38.650  Millions
Monogram technologies inc   5.08 $ 10.078  Millions$ 1.984  Millions
Lyra Therapeutics Inc   4.93 $ 87.118  Millions$ 17.686  Millions
Vivani Medical Inc   4.83 $ 29.648  Millions$ 6.138  Millions
Brainsway Ltd   4.52 $ 69.345  Millions$ 15.346  Millions
Neuropace Inc   4.50 $ 58.945  Millions$ 13.110  Millions
Outset Medical Inc   4.48 $ 226.919  Millions$ 50.670  Millions
Staar Surgical Co  4.26 $ 266.713  Millions$ 62.674  Millions
Agape Atp Corporation  4.24 $ 3.581  Millions$ 0.844  Millions
Nexalin Technology Inc   4.23 $ 2.144  Millions$ 0.507  Millions
Lemaitre Vascular Inc   4.04 $ 108.288  Millions$ 26.810  Millions
Tandem Diabetes Care Inc   4.03 $ 467.810  Millions$ 116.119  Millions
Glaukos Corp  3.78 $ 272.860  Millions$ 72.238  Millions
Cutera Inc   3.76 $ 105.444  Millions$ 28.057  Millions
Tactile Systems Technology Inc   3.72 $ 60.706  Millions$ 16.340  Millions

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.